Abstract

The amyloid precursor protein (APP) is an integral membrane glycoprotein whose cleavage products, particularly amyloid-β, accumulate in Alzheimer disease (AD). APP is present at synapses and is thought to play a role in both the formation and plasticity of these critical neuronal structures. Despite the central role suggested for APP in AD pathogenesis, the mechanisms regulating APP in neurons and its processing into cleavage products remain incompletely understood. F-box only protein 2 (Fbxo2), a neuron-enriched ubiquitin ligase substrate adaptor that preferentially binds high-mannose glycans on glycoproteins, was previously implicated in APP processing by facilitating the degradation of the APP-cleaving β-secretase, β-site APP-cleaving enzyme. Here, we sought to determine whether Fbxo2 plays a similar role for other glycoproteins in the amyloid processing pathway. We present in vitro and in vivo evidence that APP is itself a substrate for Fbxo2. APP levels were decreased in the presence of Fbxo2 in non-neuronal cells, and increased in both cultured hippocampal neurons and brain tissue from Fbxo2 knock-out mice. The processing of APP into its cleavage products was also increased in hippocampi and cultured hippocampal neurons lacking Fbxo2. In hippocampal slices, this increase in cleavage products was accompanied by a significant reduction in APP at the cell surface. Taken together, these results suggest that Fbxo2 regulates APP levels and processing in the brain and may play a role in modulating AD pathogenesis.

Highlights

  • The amyloid precursor protein (APP) is strongly implicated in the pathogenesis of Alzheimer disease

  • To determine whether F-box only protein 2 (Fbxo2) facilitates the degradation of other key glycoproteins in the amyloid processing pathway, we expressed constructs encoding full-length APP or a Myc epitope-tagged form of the ␣-secretase ADAM10 in HEK cells together with empty vector or FLAG-tagged Fbxo2 (Fig. 1)

  • We combined cell-based and animal models to show that Fbxo2 contributes to the regulation of both the steady-state levels of APP and its cleavage products

Read more

Summary

Background

The amyloid precursor protein (APP) is strongly implicated in the pathogenesis of Alzheimer disease. Results: The loss of Fbxo, a brain-enriched substrate adaptor for ubiquitin ligases, leads to increased neuronal APP levels and processing. F-box only protein 2 (Fbxo2), a neuron-enriched ubiquitin ligase substrate adaptor that preferentially binds high-mannose glycans on glycoproteins, was previously implicated in APP processing by facilitating the degradation of the APP-cleaving ␤-secretase, ␤-site APP-cleaving enzyme. This increase in cleavage products was accompanied by a significant reduction in APP at the cell surface Taken together, these results suggest that Fbxo regulates APP levels and processing in the brain and may play a role in modulating AD pathogenesis. Fbxo is an attractive candidate to contribute to APP clearance It is a neuron-enriched ubiquitin ligase substrate adaptor protein that binds glycoproteins containing high mannose N-linked glycans and facilitates their degradation through ERAD [19]. Our results suggest that the loss of Fbxo results in dysregulation of glycoprotein homeostasis in neurons with implications for APP processing

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call